Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
机构：[1]Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, China.[2]Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.[3]Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, China.[4]Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Informatization, Guangzhou, China.
第一作者机构：[1]Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, China.[2]Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, China.
推荐引用方式(GB/T 7714)：
Huang Xiaxuan,Zhang Luming,Xu Mengyuan,et al.Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus[J].Frontiers in cardiovascular medicine.2023,10:1143652.doi:10.3389/fcvm.2023.1143652.
APA：
Huang Xiaxuan,Zhang Luming,Xu Mengyuan,Yuan Shiqi,Ye Yan...&Lyu Jun.(2023).Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus.Frontiers in cardiovascular medicine,10,
MLA：
Huang Xiaxuan,et al."Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus".Frontiers in cardiovascular medicine 10.(2023):1143652
